Results 141 to 150 of about 4,593,278 (410)
TopoTxR: A topology-guided deep convolutional network for breast parenchyma learning on DCE-MRIs [PDF]
Volume 99, 2025, 103373Characterization of breast parenchyma in dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a challenging task owing to the complexity of underlying tissue structures. Existing quantitative approaches, like radiomics and deep learning models, lack explicit quantification of intricate and subtle parenchymal structures, including ...
arxiv +1 more source
Journal of the National Cancer Institute, 2020 BACKGROUND Neoadjuvant FOLFIRINOX and chemoradiation have been utilized to downstage borderline and locally advanced pancreatic ductal adenocarcinoma (PDAC).
T. Michelakos +22 more
semanticscholar +1 more source
Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study. [PDF]
, 2019 PurposeThe KRISTINE study compared neoadjuvant trastuzumab emtansine plus pertuzumab (T-DM1+P) with docetaxel, carboplatin, trastuzumab plus P (TCH+P) for the treatment human epidermal growth factor receptor 2-positive stage II to III breast cancer.
Afenjar, Karen +20 more
core
Annals of Gastroenterological Surgery, EarlyView.This retrospective study evaluates the prognostic factors in patients undergoing curative hepatic resection for rectal cancer liver metastases. It identifies lateral lymph node metastasis and perineural invasion as significant prognostic factors. Moreover, patients with these factors required nonsurgical treatment in the early postoperative period ...
Tomofumi Uotani +9 more
wiley +1 more source
Cancer treatment scheduling and dynamic heterogeneity in social dilemmas of tumour acidity and vasculature [PDF]
arXiv, 2016 Background: Tumours are diverse ecosystems with persistent heterogeneity in various cancer hallmarks like self-sufficiency of growth factor production for angiogenesis and reprogramming of energy-metabolism for aerobic glycolysis. This heterogeneity has consequences for diagnosis, treatment, and disease progression.
arxiv
Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection.
Annals of Surgery, 2019 OBJECTIVE The aim of the study was to identify the survival of patients with locally advanced pancreatic cancer (LAPC) and assess the effect of surgical resection after neoadjuvant therapy on patient outcomes.
G. Gemenetzis +13 more
semanticscholar +1 more source
Annals of Gastroenterological Surgery, EarlyView.In this nationwide inpatient database study of 5229 patients aged 70–79 years who underwent esophagectomy for cancer after neoadjuvant chemotherapy, overlap propensity score weighting analysis showed that neoadjuvant docetaxel‐based triplet regimen (docetaxel, cisplatin, and 5‐fluorouracil) was not associated with a higher incidence of perioperative ...
Yuki Hirano +11 more
wiley +1 more source
Cancer MedicineIntroduction This study aimed to compare the long‐term effects of neoadjuvant therapy and upfront surgery on overall survival (OS) and progression‐free survival (PFS) in patients with resectable pancreatic ductal adenocarcinoma (PDAC).
Kyung In Shin +14 more
doaj +1 more source
Annals of Surgery, 2019 MINI: Total neoadjuvant therapy, or systemic induction chemotherapy followed by chemoradiation, is an optimal preoperative sequencing strategy for patients with borderline resectable or locally advanced pancreatic adenocarcinoma.
M. Truty +13 more
semanticscholar +1 more source
Annals of Gastroenterological Surgery, EarlyView.This study verified the effective implementation of robotic distal pancreatectomy as the standard approach in our strategic robotic surgical oncology program. Although an institutional learning curve was observed, the robotic surgery program successfully expanded the number of primary operating surgeons while maintaining stable short‐term outcomes ...
Yuki Hirata +9 more
wiley +1 more source